Lasa Supergenerics Limited

NSE:LASA.NS

27.12 (INR) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q1
Revenue 308.355228.163266.601243.026305.56353.229317.049336.612288.787512.125157.372341.109360.66391.018539.871546.909545.997485.71392.897404.119389.84420.238538.838407.448329.206593.118609.861645.307589.556401.698
Cost of Revenue 264.789226.455241.617165.094203.051253.553255.375259.042293.173347.456121.75233.957216.998213.515289.636306.068327.717231.763217.709239.885265.779308.659468.893299.996211.663512.223406.623427.098369.108242.746
Gross Profit 43.5661.70824.98477.932102.50999.67661.67477.57-4.386164.66935.622107.152143.662177.503250.235240.841218.28253.947175.188164.234124.061111.57969.945107.452117.54380.895203.238218.209220.448158.952
Gross Profit Ratio 0.1410.0070.0940.3210.3350.2820.1950.23-0.0150.3220.2260.3140.3980.4540.4640.440.40.5230.4460.4060.3180.2660.130.2640.3570.1360.3330.3380.3740.396
Reseach & Development Expenses 000001.0220002.0230003.7360003.3810001.6430002.1530000
General & Administrative Expenses 0000038.47400058.85800065.09800041.32500039.0900032.6680000
Selling & Marketing Expenses 000003.2370000.3430000.5010000.5580000.3210002.280000
SG&A 53.5368.12941.25251.6416.92741.71168.29450.32345.04359.20127.89857.33558.27365.59942.54132.86330.24241.88335.0834.90829.96339.41129.77128.59326.82134.94825.99325.68224.47622.595
Other Expenses 0.0470.0790.0360.840.0399.3148.6050.040.086-0.3740.1310.2060.145-2.412.120.0320.383141.6473.1950.5240.917-26.2398.83410.39810.1886.355110.471135.23789.28464.93
Operating Expenses 53.5368.12941.25294.31488.50897.98117.207111.924107.5581.79283.353129.146132.099119.596165.571153.527133.754173.566137.51132.377116.37124.442124.957121.48113.399139.129110.471135.23789.28464.93
Operating Income -9.964-66.421-16.268-15.5411411.012-46.928-34.312-111.93674.496-47.731-21.99411.56357.46484.66487.31484.52680.36737.67831.8577.691-13.504-55.012-14.0284.144-58.23492.76782.972131.16494.022
Operating Income Ratio -0.032-0.291-0.061-0.0640.0460.031-0.148-0.102-0.3880.145-0.303-0.0640.0320.1470.1570.160.1550.1650.0960.0790.02-0.032-0.102-0.0340.013-0.0980.1520.1290.2220.234
Total Other Income Expenses Net -8.667-93.254-4.373-5.576-3.693-203.114-4.288-33.083-0.00140.4550.06-118.813-0.134-6.2971.36-1.879-12.237-56.06-14.213-19.474-20.485-16.803-10.543-29.375-25.908-19.802-37.721-24.218-17.206-24.347
Income Before Tax -18.631-159.675-20.641-21.11710.307-192.102-51.216-67.395-111.937114.953-47.671-140.80711.42951.16786.02485.43572.28924.30723.46512.383-12.794-30.307-65.555-43.403-21.764-78.03655.04658.754113.95869.675
Income Before Tax Ratio -0.06-0.7-0.077-0.0870.034-0.544-0.162-0.2-0.3880.224-0.303-0.4130.0320.1310.1590.1560.1320.050.060.031-0.033-0.072-0.122-0.107-0.066-0.1320.090.0910.1930.173
Income Tax Expense 8.685-6.674-6.059-20.88959.803-41.987-2.031-1.3278.902-7.89-0.53-3.3723.36913.18720.46714.92518.558-1.494-2.29916.903-2.032-12.308-12.768-23.6417.997-13.30523.906-27.88463.93115.8
Net Income -27.316-153.001-14.582-0.228-49.496-150.115-49.185-66.067-120.839122.843-47.141-137.4348.0637.97965.55670.5153.73225.80125.765-4.52-10.762-17.999-52.786-19.761-29.761-64.73131.1486.63750.02653.875
Net Income Ratio -0.089-0.671-0.055-0.001-0.162-0.425-0.155-0.196-0.4180.24-0.3-0.4030.0220.0970.1210.1290.0980.0530.066-0.011-0.028-0.043-0.098-0.048-0.09-0.1090.0510.1340.0850.134
EPS -0.55-3.05-0.29-0.005-1.22-3-1.21-1.62-2.973.02-1.16-3.380.20.931.611.731.320.630.89-0.2-0.47-0.79-2.31-0.86-1.3-2.831.363.793.082.36
EPS Diluted -0.55-3.05-0.29-0.005-1.22-3-1.21-1.62-2.973.02-1.16-3.380.20.931.611.731.320.630.89-0.2-0.47-0.79-2.31-0.86-1.3-2.831.363.793.082.36
EBITDA 17.971-39.80810.52811.27440.54252.711-16.045-3.363-81.19-8.461-11.82131.58146.41892.079127.693128.012122.172108.98784.83775.60151.23132.0212.54444.87662.3450.652136.838143.883153.676109.004
EBITDA Ratio 0.058-0.1740.0390.0460.1330.149-0.051-0.01-0.281-0.017-0.0750.3860.1290.2350.2370.2340.2240.2240.2160.1870.1310.0760.0050.110.1890.0010.2240.2230.2610.271